page_head_bg

Products

Manufacturer standard Cas No.35775-49-6 - Jujuboside A CAS No. 55466-04-1 – Yongjian

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We believe in: Innovation is our soul and spirit. High-quality is our life. Consumer need to have is our God for Cas No.84272-85-5 , Gitogenin , Cas No.55696-57-6 Manghaslin , With a wide range, good quality, realistic charges and stylish designs,Our products and solutions are widely recognized and trusted by users and can fulfill continuously changing economic and social needs.
Manufacturer standard Cas No.35775-49-6 - Jujuboside A CAS No. 55466-04-1 – Yongjian Detail:

Essential Information

Chinese alias: jujube kernel saponin A, jujube kernel saponin A; Jujube kernel saponin A (standard)

English name: Jujuboside A

Plant source: it comes from the seeds of wild jujube, also known as jujube kernel and wild jujube core

Molecular formula: C58H94O26

Molecular weight: 1207.35

CAS No. 55466-04-1

Bioactivity of Jujuboside A

Target: GABA receptor, mTOR, PI3K, Akt [1] [2]

In vitro study: low dose 41 μ Jujuboside A of M (about 0.05 g / L) induced GABA (a) receptors during 24 and 72 h treatment α 1, α 5, β 2 subunit mRNA increased significantly. High dose 82 μ M (about 0.1 g / L) Jujuboside A significantly increased GABA (a) receptors at 24 h α 1, α 5 subunit mRNA levels and decreased β 2 subunit mRNA level and decreased GABA (a) receptor subunit α 1, β 2 mRNA expression was treated at 72 h [1]. Jujuboside A pretreatment can reverse the decrease of cell viability and better induce ISO induced H9c2 cell injury. Jujuboside A can accelerate the phosphorylation of PI3K, Akt and mTOR. Jujuboside A can significantly reduce the proportion of microtubule associated protein LC3-II / I in H9c2 cells [2]

In vivo study: during the day (9:00-15:00), jujubosides significantly increased total sleep and rapid eye movement (REM) sleep, but had no significant effect on non REM (NREM) sleep. At night (21:00-3:00), jujubosides significantly increased total sleep and NREM sleep, especially mild sleep, but had no significant effect on REM sleep and slow wave sleep (SWS) [3]. Intraventricular treatment with jjuboside a was significantly alleviated by a through Y-maze, active avoidance and Morris water maze measurements β 1-42 induced learning and memory impairment in mice. Intracerebroventricular injection of Jujuboside A decreased hippocampal a β 1-42 levels significantly inhibited the activities of acetylcholinesterase (AChE) and no, and decreased the increased content of malondialdehyde (MDA) in hippocampus and cerebral cortex of mice injected into lateral ventricle β 1-42[4]。

Cell experiment: after 7 days of culture in vitro, the cells were continuously exposed for 24 hours or 72 hours, and were not exposed to the medium containing Jujuboside A or diazepam or both. Vector was added to the control group; Diazepam group added 10 μ M diazepam; Jujuboside A82 μ M (about 0.1g / L) and 41 μ M (about 0.05 g / L) was added to jua-h (high dose Jujuboside A) and jua-l (low dose Jujuboside A) groups, respectively. Total RNA was isolated from cells for further analysis [1].

Animal experiment: mice: a was injected through ICV β 1-42 induced cognitive impairment in mice. Then, mice were injected with Jujuboside A (0.02 and 0.2 mg / kg) intraventricular (ICV) for 5 days. Y maze, active avoidance and Morris water maze tests were performed on mice [1].

English Alias of Jujuboside A

α-L-arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[O-β-D-glucopyranosyl-(1->6)-O-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-

(3β,16β,23R)-20-Hydroxy-16,23:16,30-diepoxydammar-24-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->6)-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-α -L-arabinopyranoside

jujuboside C

α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[O-β-D-glucopyranosyl-(1->6)-O-[β-D-xylopyranosyl-(1->2)]- β-D-glucopyranosyl-(1->3)]-

JujubosideA

(3β,16β,23R)-20-Hydroxy-16,23:16,30-diepoxydammar-24-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->6)-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-α-L-arabinopyranoside


Product detail pictures:

Manufacturer standard Cas No.35775-49-6 - Jujuboside A CAS No. 55466-04-1 –  Yongjian detail pictures

Manufacturer standard Cas No.35775-49-6 - Jujuboside A CAS No. 55466-04-1 –  Yongjian detail pictures


Related Product Guide:

We retain bettering and perfecting our goods and service. At the same time, we perform actively to do research and enhancement for Manufacturer standard Cas No.35775-49-6 - Jujuboside A CAS No. 55466-04-1 – Yongjian , The product will supply to all over the world, such as: Portland, British, Sweden, "Good quality and reasonable price" are our business principles. If you are interested in our products or have any questions, please feel free to contact us. We hope to establish cooperative relationships with you in the near future.
  • Goods just received, we are very satisfied, a very good supplier, hope to make persistent efforts to do better.
    5 Stars By Stephanie from Philippines - 2018.05.22 12:13
    The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
    5 Stars By Cheryl from Borussia Dortmund - 2017.11.11 11:41
    Write your message here and send it to us